Table 5: Launched Liquid Biopsy Tests from Players in the Liquid Biopsy Market Table 6: Reimbursement Scenario for Key Players' Offerings in the Global Liquid Biopsy Market Table 7: Global Liquid ...

One invasive test is endomyocardial biopsy (EMB), the use of which remains controversial in the diagnosis and treatment of adult and pediatric cardiovascular disease. The use of EMB varies widely ...

The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing ...

Study shows >95% success rate, validating BE-Smart for use with esophageal brush cytology. UNIONDALE, NY, June 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the "Company” or ...

Objective IBD therapies and treatments are evolving to deeper levels of remission. Molecular measures of disease may augment current endpoints including the potential for less invasive assessments.

The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing market. With dual compatibility across standard biopsy methods, BE-Smart is ...

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 18, 2025 /PRNewswire/ -- USA ...